/ Blog / Global Point of Care Diagnostics Market – All You Need to Know


Erik Petrov1


01 December 2022

Global Point of Care Diagnostics Market – All You Need to Know

The market for point-of-care diagnostics has been greatly boosted by the rising frequency of chronic diseases and the rising demand for speedy testing, and this trend is anticipated to continue during the predicted period.


Worldwide attention on healthcare has grown, which has led to a rise in demand for near-patient testing. Medical tests are now more quick and effective than they ever were because of developments in the healthcare sector.



Point of Care Diagnostics Market



Some of the key factors influencing the rise of the global point of care diagnostics in the years to come include a shortage of skilled personnel in medical testing facilities, growing pressure on healthcare institutions, increasing emphasis on patient-centric care solutions, rising R&D spending, and the use of advanced technologies.


Although fast testing kits are very accurate and efficient, they need regulatory approval before they can be sold and used widely in healthcare facilities. Due to the strict standards set by these regulatory agencies, it takes longer for businesses to obtain approval for their products, which limits the potential market for point-of-care diagnostics as a whole.


The growing presence of chronic illnesses is expected to drive the rise of the global point of care diagnostics market in Europe, which is predicted to account for a sizeable portion of the global industry. Due to the growing emphasis on healthcare, the point of care diagnostics market in the Asian area is also anticipated to grow strongly over the next years.


The market for global point of care diagnostics is presented in great detail in the current study. The market possibilities for global point of care diagnostics is also highlighted in this study, along with a thorough analysis of the trends, opportunities, market drivers, regulatory environment, and competitive landscape. The research also discusses important market participants and industry estimates through 2026.


Moreover, the report also vastly covers the numerous resources of the global point of care diagnostics sector. It includes analytics, software, and hardware for the entire point-of-care diagnostics business.


The market is further examined based on test type in the report, which also includes analyses of tests for urine chemistry, tumor markers, fertility and pregnancy, infectious disease, hemostasis/ hemoglobin, glucose monitoring, cholesterol, cardiac markers, BGEM, and drug and alcohol abuse. The report also examines a thorough regional understanding of the market.


The market has been divided into Africa, Middle East, Latin America, Asia-Pacific, Europe, and North America based on geography. Major nations with in-depth evaluations include India, China, Japan, Italy, Spain, France, the UK, Germany, Canada, and the US. With predictions for 2021 through 2026, statistics have been supplied for market estimates using 2020 as the base year. Values that have been estimated are based on total sales for product producers.


Revenue amounts that have been projected and expected are expressed in dollars that have not been prorated for inflation.


The diagnostic testing market is a multi-billion dollar one with fierce rivalry and promising development opportunities. The world's biggest marketplace for diagnostic tests is in the United States. The POC sector is the main focus of the report and it is one of the busiest subsectors of the diagnostic marketplace.


Both POC testing and home use near-patient uses are expanding. This market analysis covers both market divisions. The increased occurrence of infectious diseases is the main driver boosting the POC diagnostics industry. POC tests aid in improving the administration of transferable diseases, especially in developing nations where a lack of healthcare infrastructure makes it challenging to obtain an accurate diagnosis in a timely manner.


Government funding and incentives for product development and advancement are helping to spread breakthrough technology for the early identification of transmittable diseases. All of these market innovations are anticipated to extend the use of POC devices to distant regions in undeveloped and developing countries, make them more portable, and enable the adoption of these devices by the economically underprivileged population. The presence of chronic illnesses, such as diabetes is rising, which is helping the global market expand.


The key factor impeding market expansion is the stringent guideline for commercialization and approval. POC devices are subject to the same regulations as other diagnostics and in vitro equipment.


POC devices need pre-market approval since the FDA deems them to be high risk. Strict healthcare regulations and substantial regulatory hurdles significantly hinder the adoption of cutting-edge technology. Pre-market approval and the commercialization process took longer due to the tight laws and standards, which demanded significant knowledge to traverse.


The global point-of-care diagnostics market research offers comprehensive details on market trends and current developments. Additionally, this study emphasizes the development methods used by the major market participants, including partnerships, alliances, acquisitions, and mergers.


Further discussion of the report's restraints and drivers affecting market growth throughout the projection period follows. Along with the most recent product introductions made by the major market participants, the impact of the pandemic on market growth and expansion is further discussed. The remainder of this paper includes a list of significant market participants and details on local markets.


Due to increased rates of chronic diseases and the rise of infectious diseases, the global marketplace for point-of-care diagnostics is anticipated to expand significantly throughout the forecast period. Additionally, the market is anticipated to be driven by the rising popularity of decentralized health systems. Moreover, it is anticipated that the market would grow during the predicted period due to the adoption of new breakthroughs and technical improvements in the sector by key market players. In the upcoming years, growth in the point-of-care diagnostics market is anticipated as a result of these factors. The market's expansion could be hampered by rising hazards and poor test execution, though.


Numerous sectors were impacted by the COVID-19 epidemic in terms of income and output. The epidemic has, however, had a favorable effect on the healthcare industry. Due to an increase of COVID-19 cases and a rise in the need for frequent tests, point-of-care diagnostics were in great demand in the market. Important market firms have introduced new items in response to consumer demand during the pandemic. These elements have supported market expansion during the epidemic period.


Click here now to get your hands on this report to get a complete analysis of the market trends and forecast for the global point of care diagnostics market. 


Share on

Continue Reading

All About Focus Group | The Ultimate Step-By-Step Guide

Click here to develop a solid understanding of focus groups. In this comprehensive guide, we will explain what’s a focus group, its benefits, and more.

Uber's Computer Systems Just Got Hacked

Click to learn about the recent hack at Uber, what went down, what the likely reason is, what we know about the hacker, and what it all means.

Sol-Gel Acquires FDA Approval For Its Encapsulated Skin Disease Drug

Sol-Gel Technologies is one of the most well-reputable names for developing innovative and safe medications for skin diseases. The dermatology organization specializes in recognizing, creating, and commercialising generic and branded topical drugs and drug products to treat a plethora of skin diseases.

False Botulinum Toxin Product Causing Stir

Dysport and Botulinum Toxin, commonly known as Botox, are used for similar purposes in the medical industry. Dysport is used for removing glabellar lines and light wrinkles, and has also been FDA-approved for lower limb spasticity and cervical dystonia. Both the substances are introduced into the body through intramuscular injections, and care must be taken by the clinic in question to ensure sterile conditions for injecting each substance.

Recent Press Releases

Douglas Insights Adds Master Data Management Market Research Reports to Its Comparison ...

Douglas Insights has expanded its comparison engine with Master Data Management Market research reports, allowing market researchers, analysts, industry expe...

Douglas Insights Includes Insecticides Market Research Reports to Its Comparison Engine

Douglas Insights has added the Insecticides Market research to its growing market reports. Douglas insight is one of the best comparison engines out there. T...

Douglas Insights Adds Custom T-Shirt Printing Market Research Reports to Its Comparison...

Douglas Insights wanted to expand its comparison engine with market reports that identify all the players in a market space. They also contain notes from res...

Douglas Insights Adds Industrial Shredder Market Research Reports to Its Comparison Engine

Douglas Insights has added Industrial Shredder Market research reports in its comparison engine. These reports enable market analysts and researchers to gain...